Create Free Account

By creating account you will get access to hot stocks & personalised emails

Micro-X Ltd

Healthcare AU MX1

0.09AUD
-0.004(4.26%)

Last update at 2024-05-02T05:29:00Z

Day Range

0.090.09
LowHigh

52 Week Range

0.090.16
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -10.75400M -17.08900M -14.73100M -10.06700M -9.83400M
Minority interest - - - - -
Net income -10.75400M -17.08900M -14.73100M -10.06700M -10.32900M
Selling general administrative 17.79M 16.67M 10.90M 6.82M 5.83M
Selling and marketing expenses 1.38M 0.86M 0.21M - -
Gross profit 11.50M 5.00M -0.14000M 0.70M 0.17M
Reconciled depreciation 1.66M 1.43M 2.33M 1.97M 0.74M
Ebit -10.48500M -16.79300M -14.05100M -9.21100M -9.33900M
Ebitda -8.82600M -15.36100M -11.72200M -7.24500M -8.59500M
Depreciation and amortization 1.66M 1.43M 2.33M 1.97M 0.74M
Non operating income net other - - - - -
Operating income -17.87500M -20.93700M -17.06300M -12.51200M -9.33900M
Other operating expenses -5.59300M -8.95600M -7.55600M -1.44100M 15.18M
Interest expense 0.27M 0.30M 0.68M 0.86M 0.49M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 0.00100M 0.02M 0.00600M 0.86M 0.03M
Net interest income -0.26800M -0.27500M -0.67400M -0.85600M -0.48500M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 7.66M 4.42M 3.69M 4.15M 0.49M
Total revenue 15.01M 8.97M 3.77M 4.25M 1.93M
Total operating expenses 29.45M 25.94M 16.92M 13.21M 13.41M
Cost of revenue 3.50M 3.97M 3.91M 3.55M 1.76M
Total other income expense net 7.39M 4.12M 3.01M 3.29M -0.49500M
Discontinued operations - - - - -
Net income from continuing ops -10.75400M -17.08900M -14.73100M -10.06700M -9.83400M
Net income applicable to common shares -10.75400M -17.08900M -14.73100M -10.06700M -9.83400M
Preferred stock and other adjustments - - - - -
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Total assets 30.30M 31.28M 44.68M 33.70M 9.87M
Intangible assets 0.13M 0.14M 0.13M 1.04M 1.83M
Earning assets - - - - -
Other current assets 1.63M 1.31M 0.36M 0.07M 0.01M
Total liab 13.11M 11.99M 10.47M 18.80M 12.85M
Total stockholder equity 17.19M 19.29M 34.21M 14.90M -2.97800M
Deferred long term liab 0.05M 0.06M - 0.84M 1.56M
Other current liab 4.61M 4.08M 2.52M 7.20M 2.53M
Common stock 125.40M 117.53M 116.97M 84.30M 51.25M
Capital stock 125.46M 117.59M 117.03M 84.46M 56.25M
Retained earnings -112.13400M -101.38000M -84.29100M -69.97700M -60.63200M
Other liab 0.81M 0.83M 0.92M 1.07M 2.26M
Good will - - - - -
Other assets 0.05M 0.06M - 0.84M 1.56M
Cash 5.22M 10.30M 30.14M 18.32M 1.61M
Cash and equivalents 5.22M 10.30M 30.14M 18.32M 1.61M
Total current liabilities 8.32M 6.48M 4.31M 8.74M 7.59M
Current deferred revenue 0.50M 0.46M 0.50M -3.58100M -
Net debt -0.52000M -4.98900M -24.29800M -5.74900M 4.39M
Short term debt 0.73M 0.63M 0.60M 3.58M 3.00M
Short long term debt - - - 3.00M 3.00M
Short long term debt total 4.70M 5.31M 5.84M 12.57M 6.00M
Other stockholder equity -13.26200M -16.14900M -32.67600M -14.32000M 5.00M
Property plant equipment 7.73M 8.39M 8.74M 7.26M 1.75M
Total current assets 22.44M 22.74M 35.81M 25.40M 6.29M
Long term investments - - - - -
Net tangible assets 17.11M 19.14M 34.08M 14.71M -3.24600M
Short term investments - - - - 0.00000M
Net receivables 7.00M 3.75M 2.48M 5.20M 3.41M
Long term debt - - 0.00000M 5.53M 5.00M
Inventory 7.34M 5.78M 2.84M 1.81M 1.27M
Accounts payable 2.48M 1.30M 0.69M 1.54M 2.06M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 3.87M 3.08M 1.47M 0.42M 1.41M
Additional paid in capital - - - - -
Common stock total equity - - - 84.30M 51.25M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - -8.86600M - 3.58M
Deferred long term asset charges - - - - -
Non current assets total 7.86M 8.53M 8.87M 8.30M 3.58M
Capital lease obligations 4.70M 5.31M 5.84M 4.85M -
Long term debt total 3.98M 4.68M 5.24M 9.80M 5.00M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -0.77900M -1.11200M -0.90100M -2.19900M -1.70800M
Change to liabilities 1.89M 0.67M -1.70700M 0.41M 1.07M
Total cashflows from investing activities -0.77900M -1.11200M -0.90100M -2.19900M -1.70800M
Net borrowings -0.65800M -0.61200M -9.43100M -0.91600M 4.40M
Total cash from financing activities 6.69M -0.61200M 22.57M 28.37M 6.40M
Change to operating activities 0.11M 0.32M 0.78M 0.30M 0.12M
Net income -10.75400M -17.08900M -14.73100M -10.06700M -9.83400M
Change in cash -5.08000M -19.83200M 11.82M 16.71M -2.46200M
Begin period cash flow 10.30M 30.14M 18.32M 1.61M 4.07M
End period cash flow 5.22M 10.30M 30.14M 18.32M 1.61M
Total cash from operating activities -10.99300M -18.10800M -10.11300M -9.45600M -7.15400M
Issuance of capital stock 7.46M - 34.00M 31.50M 2.00M
Depreciation 1.60M 1.37M 1.45M 1.25M 0.74M
Other cashflows from investing activities - - - - -
Dividends paid - - - -5.00000M 2.22M
Change to inventory -1.52100M -2.88700M -1.02600M -0.54300M 0.28M
Change to account receivables -3.54300M -2.59200M 2.43M -1.85200M 1.08M
Sale purchase of stock -0.10500M -0.10500M -1.99400M -2.21800M -2.21800M
Other cashflows from financing activities -0.65800M -0.61200M -6.43100M 9.90M 10.44M
Change to netincome 1.23M 2.04M 2.10M 0.33M -0.61000M
Capital expenditures 0.78M 1.11M 0.90M 2.20M 1.71M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -5.06400M -5.47900M 1.41M -2.39500M 4.94M
Stock based compensation 1.23M 1.95M 1.68M -0.26500M -
Other non cash items -1.84000M -2.39200M 3.16M -0.63500M 9.09M
Free cash flow -11.77200M -19.22000M -11.01400M -11.65500M -1.70800M

Fundamentals

  • Previous Close 0.09
  • Market Cap52.07M
  • Volume500995
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-21.00800M
  • Revenue TTM15.17M
  • Revenue Per Share TTM0.03
  • Gross Profit TTM 5.06M
  • Diluted EPS TTM-0.03

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
MX1
Micro-X Ltd		 -0.004 4.26% 0.09 - - 4.10 6.25 4.04 -4.8731
COH
Cochlear Ltd		 -0.88 0.28% 316.29 59.34 46.30 9.75 11.76 9.62 36.63
PNV
Polynovo Ltd		 -0.04 1.95% 2.01 - 140.85 17.37 21.49 17.51 647.42
AVR
Anteris Technologies Ltd		 -0.4 1.84% 21.30 - - 104.23 14.98 95.15 -5.9152
AVH
Avita Therapeutics Inc		 0.10 3.80% 2.73 - - 8.59 5.71 6.72 -10.0538

Reports Covered

Stock Research & News

View All

Profile

Micro-X Limited designs, develops, manufactures, and commercializes medical and security imaging products using cold cathode X-ray technology for the healthcare and security markets in Australia. The company offers rover veterinary, a mobile X-ray machine to diagnose and treat animals for general veterinarian practices; rover medical; IED X-ray cameras; miniature baggage scanners to detect hidden threats within passenger carry-on luggage; brain CT scanners for use in road and air ambulances; and DRX-Revolution Nano, a mobile X-ray imaging machine used for high intensity workflow diagnostic medical imaging in hospitals. The company was incorporated in 2011 and is based in Tonsley, Australia.

Micro-X Ltd

A14, 6 MAB Eastern Promenade, Tonsley, SA, Australia, 5042

Key Executives

Name Title Year Born
Mr. Peter Robin Rowland BSc., CEng, FAICD, MBA, MIET MD, CEO & Director NA
Mr. Kingsley Hall BEC CFO & Company Sec. NA
Mr. Alexander Blackburn BEng (Hons), M.B.A. Head of Strategy & Planning and GM of X-Ray Cameras NA
Mr. Anthony Skeats MEng (Hons) Chief Engineer & GM of Computed Tomography NA
Dr. Brian Gonzales GM of Checkpoints & Chief Imaging Scientist NA
Mr. Charlie Hicks Gen. Mang. of Mobile Digital Radiology & Division Head NA
Daniel Pini Gen. Mang. of Core Technology NA
Mr. Dan Ginsburg Bus. & Operations Mang. NA
Ms. Bree Farrugia Gen. Counsel NA
Ms. Lois Newman Head of EMEA Sales- Mobile DR NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).

Our Company

Useful Links

Contact Us

Market Research

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.